Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 13 results

Author Title [ Type

] Year

Filters: Author is Treanor, J [Clear All Filters]

Journal Article

El-Kamary, S., Pasetti, M., Mendelman, P., Frey, S., Bernstein, D., Treanor, J., et al.. (2010). Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues. J Infect Dis, 202, 1648-1658. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20979455

Frenck, Jr, R. W., Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., et al.. (2011). Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults. Vaccine, 29, 5666-5674. presented at the 08/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21699951

King, J. C., Treanor, J., Fast, P. E., Wolff, M., Yan, L., Iacuzio, D., et al.. (2000). Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis, 181(2), 725-8. presented at the 2000 Feb. doi:10.1086/315246

King, J. C., Treanor, J., Fast, P. E., Wolff, M. C., Yan, L., Iacuzio, D., et al.. (2000). Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults. J Infec Dis, 181, 725-8. presented at the 2000.

Belshe, R. B., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., et al.. (2000). Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis, 181(3), 1133-7. presented at the 2000 Mar. doi:10.1086/315323

Belshe, B. R., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., et al.. (2000). Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infec Dis, 181, 11133-7. presented at the 2000.

Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W., Piedra, P., et al.. (1998). The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children. N Engl J Med, 338, 1405-12. presented at the 1998.

Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., et al.. (1998). The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med, 338(20), 1405-12. presented at the 1998 May 14. doi:10.1056/NEJM199805143382002

Belshe, R. B., Gruber, W., Mendelman, P. M., Cho, I., Reisinger, K., Block, S., et al.. (2000). Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine. J Pediatric, 136, 168-175. presented at the 02/2000. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10657821

Belshe, R. B., Gruber, W. C., Mendelman, P. M., Cho, I., Reisinger, K., Block, S. L., et al.. (2000). Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr, 136(2), 168-75. presented at the 2000 Feb. doi:10.1016/s0022-3476(00)70097-7

Treanor, J., Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., et al.. (2002). Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults. Vaccine, 20, 1099-1105. presented at the 2002.

Pichichero, M. E., Gentile, A., Giglio, N., Umido, V., Clarkson, T., Cernichiari, E., et al.. (2008). Mercury Levels in Newborns and Infants after Receipt of Thimerosal-Containing Vaccines. Pediatrics, 121, e208-e214. presented at the 02/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18245396

Bernstein, D., Atmar, R. L., Lyon, G. M., Treanor, J., Chen, W. H., Jiang, X., et al.. (2014). Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults. J Infect Dis, jiu497 [pi. presented at the 09/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25210140